Dentistry and Craniofacial Research

Management of oral cavity disorders during chemotherapy in oncologic pediatric patients

27^th International Conference on Dentistry and Dental Practice
January 28-29, 2019 Barcelona, Spain

Ketevan Nanobashvili

University of Georgia, Georgia

Keynote: J Den Craniofac Res

DOI: 10.21767/2576-392X-C1-013

Abstract

Chemotherapy is an important part of modern methods for the treatment of oncologic diseases. As any medication or method, the chemotherapeutical agents also have complications and side effects, from which our interest is the changes in oral cavity during and after cancer treatment. By using chemotherapeutic agents, the majority of patients may develop the complications of the oral health. The literature describes mucositis, oral pain, infection, hemorrhagias, xerotomy, neurological and nutritional problems. Each of them is a potential threat to the patient’s general condition, according to chronological or dental age - for oral hard or soft tissues. These factors will cause significant violations in future permanent dentition, and problems such as dysphagia, dysphonia, development of oral organs and face. Unfortunately, in literature there is less information about the condition of pediatric patients, which are subject of chemotherapy for oncologic diagnosis. Accordingly, there is less information about maintaining the conditions for facilitating prevention of dangerous changes and for the development of future permanent dentition. The goal of the research is to find information about frequency and quality of the damage in oral cavity caused by chemotherapy in oncologic pediatric patients. Also, to develop the special methodology to avoid and prevent vulnerability of the child’s health conditions because of pathological changes in oral cavity. Key questions for research project are: What is the frequency of developing of alveolar bone resorbtion during chemotherapy in pediatric population?; exactly which chemotherapeutical agent forces the alveolar bone resorbtion during chemotherapy in pediatric population?; How is it possible to manage the alveolar bone resorbtion during chemotherapy in pediatric population?; How to prevent the future permanent dentition from disorders during chemotherapy in pediatric population?

Biography

Ketevan Nanobashvili has completed her PhD in Medicine at Tbilisi State Medical University and Postdoctoral studies at University of Georgia and at a dental clinic “Dream Dental and Esthetic Group”. She has worked as a Professor of Dentistry at Tbilisi Medical Academy and University of Georgia. She has published about 15 papers in reputed journals.

E-mail: K.nanobashvili@ug.edu.ge